ShoreHaven Wealth Partners’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-306	Closed	-$28K	–	133
2021 Q1	$28K	Buy	+306	New	+$28K	0.02%	147